infliximab

Ukraine

Drugs containing this active substance

RENFLEXIS

The drug is prescribed for the treatment of rheumatoid arthritis, Crohn's disease (in adults and children), ulcerative colitis (in adults and children), ankylosing spondylitis, psoriatic arthritis, and psoriasis.

Form: powder for concentrate for infusion solution

Active substance	Dosage
infliximab	100 mg

ATC: L04AB02

Manufacturer: Pfizer Italia S.p.A. (manufacturing GLZ; quality control at batch release for parameter "Sterility") / PPD Development, L.P. (quality control in stability study for parameter "Neutralization analysis of TNF-alpha using NF-kB reporter gene")